Drug
Aspirin-phosphatidylcholine clinical trials
A product of Aspirin; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 2
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
PLx Pharma (4)
Studies
Open first, then newest update. How each study uses aspirin-phosphatidylcholine is read from its arms, and is right about nine times in ten.
Testing it · 4
- Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk SubjectsCompletedPhase 2PLx PharmaNCT01646814Written as PL2200
- Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic PatientsCompletedPhase 3PLx PharmaNCT01515657Written as PL2200 Aspirin Capsules
- Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic PatientsCompletedPhase 3PLx PharmaNCT02008942Written as PL2200 Aspirin Capsules
- Food-Effect Pharmacokinetic Study of PL2200CompletedPhase 1PLx PharmaNCT01244100Written as PL2200 fasted